Abstract Although arsenic trioxide (ATO) has been the subject of toxicological research, in vitro cytotoxicity and genotoxicity studies using relevant cell models and uniform methodology are not well elucidated. Hence, the aim of the present study was to evaluate the cytotoxicity and genotoxicity induced by ATO in a human leukemia (HL-60) cell line using the MTT [3-(4, 5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide] and alkaline single cell gel electrophoresis (Comet) assays, respectively. HL-60 cells were treated with different doses of ATO for 24 h prior to cytogenetic assessment. Data obtained from the MTT assay indicated that ATO significantly (P < 0.05) reduced the viability of HL-60 cells in a dose-dependent manner, showing a LD 50 value of 6.4 ± 0.6 lg/mL. Data generated from the comet assay also indicated a significant dose-dependent increase in DNA damage in HL-60 cells associated with ATO exposure. We observed a significant increase (P < 0.05) in comet taillength, tail arm and tail moment, as well as in percentages of DNA cleavage at all doses tested, showing an evidence of ATO-induced genotoxic damage in HL-60 cells. This study confirms that the comet assay is a sensitive and effective method to detect DNA damage caused by heavy metals like arsenic. Taken together, our findings suggest that ATO exposure significantly (P < 0.05) reduces cellular viability and induces DNA damage in HL-60 cells as assessed by MTT and alkaline single cell gel electrophoresis assays, respectively.
Introduction
Although arsenic trioxide (ATO) is a well-known toxicant, it has been in medical use for a long time. Arsenic containing compounds have been used for at least a century in the treatment of syphyllis, yaws, amoebic dysentery, and trypanosomiasis [1, 2] . Recently, ATO (Trisenox) has been used as an anticancer agent in the treatment of acute promyelocytic leukemia, and its therapeutic action has been associated with its ability to induce apoptosis with down regulation of Bcl-2 expression and modulation of the PML-RARa/ PML proteins in leukemic cells both in vivo and in vitro [3] . This is indicative of the potential mechanism of action of ATO at low doses, and therefore, its use as a salvage therapy for relapsed and refractory acute promyelocytic leukemia [4] . ATO has also been reported to have activity in vitro against myeloma cell lines and primary myeloma cells [4] . Moreover, it has been shown to inhibit cell viability and proliferation, as well as to induce programmed cell death in a panel of lymphoma cell lines [5] .
Nonetheless, exposure to arsenic has been associated with anemia, peripheral neuropathy, liver and kidney damage, irritation of the skin and mucous membranes, vascular disease, and several types of cancer, such as skin, liver, lung, bladder, and kidney neoplasms [6] [7] [8] [9] . In chronic arsenic exposure, many other clinical symptoms including headache, fatigue, confusion, polyneuritis with distal weakness, exfoliative dermatitis, leucopenia, hyperkeratosis, vomiting, and hyperpigmentation have been reported [9] . Scientific reports from epidemiological studies have also pointed out an association between exposure to inorganic arsenic and increased risk of adverse developmental effects such as congenital malformations, low birth weight, and spontaneous abortion [10, 11] .
Impairment of cellular respiration, characterized by the inhibition of various mitochondrial enzymes and the uncoupling of oxidative phosphorylation is considered as one of the major mechanisms by which arsenic exerts its toxic effects. In addition, arsenic toxicity results from its ability to interact with sulphydryl groups of proteins and enzymes, and to substitute phosphorous group in a variety of biochemical reactions [12] . Schwerdtle and his colleagues have reported that ATO binds strongly to sulfhydryl groups and dithiols, and modifications in the glutathione redox system can lead to inhibited DNA repair, mutation in key genetic sites, or increased cell proliferation which can result in subsequent mutation by inhibiting the DNA repair apparatus [13] .
Few studies suggest that the mechanism of genotoxicity of arsenic compounds may be due to the ability of arsenite to inhibit DNA replicating or repair or to the ability of arsenate to act as phosphate analog enzyme [11] . Arsenic-induced oxidative stress can provoke a broad spectrum of effects on the DNA including DNA single-and double-strand breaks, abasic sites, DNA-protein cross-links, and DNA base modifications [14] . Among the DNA base modifications, 7, 8-dihydro-8-oxoguanine (8-hydroguanine) has received special attention because it is mutagenic by causing GC-TA transversions [15] . The scavenging of reactive oxygen species by superoxide dismutase, catalase, glutathione peroxidase, and dimethyl sulfoxide (DMSO) can counteract the deletion of mutations in human chromosomes as well as sister chromatid exchanges and thus exercise a collateral damaging effect on the DNA [14, 16] .
Research has shown that ATO can be mutagenic in mammalian cells in culture. Reversion assays with Salmonella typhimurium fail to detect mutations that are induced by arsenic compounds [17] . Tests for genotoxicity have indicated that arsenic compounds inhibit DNA repair, induce chromosomal aberrations, and sister chromatid exchanges [11, 18] . In vitro experiments with many inorganic and organic arsenicals have shown that they are powerful clastogens in many cell types [19, 20] . Both in vitro and in vivo genotoxic studies have indicated that ATO induces DNA damage in human lymphocytes and in mice leucocytes based on the comet assay [21] .
In a recent in-vivo study, we also demonstrated that ATO is genotoxic and able to induce structural chromosomal aberrations and micronuclei formation in bone marrow cells of Sprague-Dawley rats [18] . Studies in our laboratory have demonstrated that ATO, in vitro, is cytotoxic to human liver carcinoma (HepG 2 ) cells, and is able to transcriptionally activate a significant number of stress genes and related proteins in human liver carcinoma (HepG 2 ) cells [22, 23] . In the present study, we use the HL-60 human leukemia cell line as a test model to evaluate ATOinduced cytototoxicity and genotoxicity using the MTT [3-(4, 5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide] and alkaline single cell gel electrophoresis (Comet) assays, respectively; based on its recent consideration as a salvage therapy in the treatment of acute promyelocytic leukemia.
Materials and methods

Chemicals and test media
Arsenic trioxide (As 2 O 3 ), CASRN 1327-53-3, MW 197.84, with an active ingredient of 100% (w/v) arsenic in 10% nitric acid was purchased from Fisher Scientific in Houston, Texas. Growth medium RMPI 1640 containing 1 mmol/L L-glutamine was purchased from Gibco BRL products (Grand Island, NY). Ninety-six well plates were purchased from Costar (Cambridge, MA). Fetal bovine serum (FBS), antibiotics (penicillin G and streptomycin), phosphate buffered saline (PBS), and MTT assay kit were obtained from Sigma Chemical Company (St. Louis, MO).
Tissue culture
The HL-60 promyelocytic leukemia cell line was purchased from the American Type Culture Collection--ATCC (Manassas, VA). It is a promyelocytic cell line derived from peripheral blood cells from a 36 year-old Caucasian female with acute promyelocytic leukemia (APL). The HL-60 cells grow as a suspension culture. The predominant cell population consists of neutrophilic promyelocytes [24, 25] .
In the laboratory, cells were stored in the liquid nitrogen until use. They were thawed by gentle agitation of their containers (vials) for 2 min in a water bath at 37°C. After thawing, the content of each vial of cells was transferred to a 25 cm 2 tissue culture flask, diluted with up to 10 mL of RMPI 1640 containing 1 mmol/L L-glutamine (GIBCO/BRL, Gaithersburg, MD) and supplemented with 10% (v/v) fetal bovine serum (FBS), and 1% (w/v) penicillin/streptomycin. The 25 cm 2 culture flasks containing 2 · 10 6 viable cells were observed under the inverted microscope, followed by incubation in a humidified 5% CO 2 incubator at 37°C. Three times a week, they were diluted and maintained under same conditions at a density of 5 · 10 5 /mL and harvested in the exponential phase of growth. The cell viability was assessed by the trypan blue exclusion test (Life Technologies) and manually counted using a hemocytometer.
Cytotoxicity/MTT assay
Principle of the assay
This is a colorimetric assay that measures the reduction of 3-(4, 5-dimethylthiasol-2-yl)-2, 4,-diphenyltetrazolium bromide (MTT) by mitochondrial succinate dehydrogenase. The MTT reagent enters the cells and passes into the mitochondria where it is reduced to an insoluble, colored, formazan product. The cells are then solubilised with an organic solvent (DMSO or isopropanol) and the released; solubilised fromazan product is measured by spectro-photometry. The amount of color produced is directly proportional to the number of viable cells [26, 27] .
Method
Human leukemia HL-60 cells were maintained in RMPI 1640 containing 1 mmol/L L-glutamine, supplemented with 10% (v/v) fetal bovine serum (FBS), 1% (w/v) penicillin/streptomycin, and incubated at 37°C in humidified 5% CO 2 incubator. To 180 lL aliquots in six replicates of the cell suspension (5 · 10 5 /mL) seeded to 96-well polystyrene tissue culture plates, 20 lL aliquots of stock solutions were added to each well using distilled water as solvent to make-up final ATO doses of 0.04, 0.08, 0.156, 0.313, 0.625, 1.25, 2.5, 5, 10, and 20 lg/mL. Control cells received 20 lL of distilled water. All chemical exposures were carried in 96-well tissue culture plates for the purpose of chemical dilutions. Cells were placed in a humidified 5% CO 2 incubator for 24 h at 37°C. After incubation, 20 lL aliquots of MTT solution (5 mg/mL in PBS) were added to each well and re-incubated for 4 h at 37°C following by low centrifugation at 800 rpm for 5 min. Then, the 200 lL of supernatant culture medium were carefully aspirated and 200 lL aliquots of dimethylsulfoxide (DMSO) were added to each well to dissolve the formazan crystals, followed by incubation for 10 min to dissolve air bubbles. The culture plate was placed on a Biotek micro-plate reader and the absorbance was measured at 550 nm. All assays were performed in six replicates for each ATO dose.
Statistical analysis was done to determine the means ± SDs of cell viability. Cell viability rate was calculated as the percentage of MTT absorption as follows: % survival = (mean experimental absorbance/ mean control absorbance · 100).
Cell treatment for comet/genotoxicity assay Cells were counted (10,000 cells/well) and resuspended in the growth medium with 10% FBS. Aliquots of 100 lL of the cell suspension were placed in each well of 96-well plates, treated with 100 lL aliquot of either media or ATO (2.5, 5, and 10 lg/mL) and incubated in a humidified 5% CO 2 incubator at 37°C for 24 h. After incubation, the cells were centrifuged, washed with PBS free calcium and magnesium, and re-suspended in 100 lL PBS. In a 2 mL tube, 50 lL of the cells suspension and 500 lL of melted LMAgarose were mixed, and 75 lL pipetted onto a pre-warmed cometslide. The side of the pipette tip was used to spread completely agarose/cells over the sample area. The slides were placed flat in the dark at 4°C for 10 min to allow the mixture to solidify, and then immersed in pre-chilled lysis solution at 4°C for 40 min. Slides were removed from lysis solution, tapped, and immersed in alkaline solution for 40 min at room temperature in the dark. Slides were washed twice for 5 min with tris-borate-EDTA (TBE). Slides were electrophoresed at low voltage (300 mA, 25 V, 4°C) for 20 min. After electrophoresis, the slides were placed in 70% ethanol for 5 min, removed, tapped, and air dried overnight. Slides were stained with Silver stain or SYBR Green stain designed for the Comet assay, and allowed to air dry at room temperature for 6 h.
Silver-stained cometslides were viewed using a phase contrast microscope and images were obtained using a digital camera. Three hundred cells were randomly selected from three replicated cometslides per ATO dose at 20· magnification under the microscope. The comets were classified visually into five categories according to the appearance resulting from the relative proportion of DNA in the tail. The extent of DNA damage was expressed in arbitrary units: Class 0--control cell with no DNA damage and no tail (intact nuclei); Class 1--comet cell with short tail (tail length less than the head diameter); Class 2--comet cell with tail length longer than the head diameter and with low DNA damage; Class 3--comet cell with tail length longer than the head diameter and with high DNA damage; and Class 4--comet cell with tail length longer than the head diameter, high DNA damage, and insignificant head [16] .
SYBR Green-stained cometslides were viewed with an Olympus fluorescence microscope and analyzed using LAI's Comet Assay Analysis System software (Loates Associates, Inc. Westminster, MD).
Statistical analysis
Cytotoxicity assay data Cell viability percentages were calculated from the optimal density readings at 550 nm, using the Xenometrix computer software program [28] . Results were presented as means ± SDs. Statistical analysis was done using one way analysis of variance (ANOVA) for multiple samples and Student's t-test for comparing paired sample sets. Statistical significances were considered at P-values less than 0.05. The percentages of cell viability were presented graphically in the form of histograms, using Microsoft Excel computer program.
Comet/genotoxicity assay data
In the case of Silver stained cometslides, a total of 300 comets were scored per ATO dose. One hundred comets were randomly selected from three replicated slides by visual scoring at 20· magnification under a phase contrast microscope, according to the degree of DNA damage and comet tail length as described in the Materials and Methods.
In the case of SYBR Green stained cometslides, a total of 150 comets were scored per ATO dose. Seventy-five comets were randomly selected from three replicated slides using LAI's Comet Assay Analysis System software (Loates Associates, Inc. Westminster, MD). The data from three experiments were pooled and the means ± SDs were calculated.
The least significant difference (LSD) test was used to determine statistical differences between the control cells and ATO-treated HL-60 cells. All P-values < 0.05 were considered to be significant. The percentage of DNA cleavage, comet tail length, tail arm and tail moment of control, and ATO-treated HL-60 cells were presented graphically in the form of histograms, using Microsoft Excel computer program.
Results
Cytotoxicity/MTT assay
The results of the cytotoxicity of ATO to human leukemia (HL-60) cells are presented in (Fig. 1) . Data obtained from this assay indicated a strong doseresponse relationship with regard to the cytotoxic property of ATO. As indicated in this figure, there was a gradual decrease in the viability of HL-60 cells, with increasing doses of ATO. Upon 24 h of exposure, the mean percentages of cell viability were 100 ± 13; 109 ± 10; 107 ± 13; 76 ± 11; 66 ± 18; 53 ± 6; 54 ± 3; 53 ± 2; 48 ± 5; 16 ± 3 and 3 ± 3 in 0, 0.04, 0.08, 0.16, 0.31, 0.62, 1.25, 2.5, 5, 10, and 20 lg/mL of ATO, respectively. The chemical dose required to cause 50% reduction in cell viability was computed to be 6.4 ± 0.6 lg/mL. These results showed that ATO induced a slight increase in cell viability between 0 lg/ mL (control) and 0.08 lg/mL, followed by a gradual decrease between 0.16 and 20 lg/mL. We previously reported a similar chemical hormesis effect from a study of the cytotoxicity of ATO to human liver carcinoma cells [23] . HL-60 cells exposed to ATO doses of 0.31, 0.62, 1.25, 2.5, 5, 10, and 20 lg/mL showed significant mortalities (P < 0.05) compared to control cells, according to ANOVA Dunnett's test (Fig. 1) .
Comet assay using silver stain Representative comet assay images of control and ATO-treated HL-60 cells using the silver staining protocol are presented in (Fig. 2) . These results indicated that the distribution of cells by comet classes was highly dependent of the dose of ATO. For example, in the control (0 lg/mL ATO), we found about 62%, 25%, and 13% of cells in Class 0, Class 1, and Class 2, respectively, and 0% in Classes 3 and 4. In contrary, about 70%, 47%, and 2% of cells were found in Class 4, Class 3, and Class 1, respectively following exposure to the 10 lg/mL dose. In general, there was a gradual increase in the percentage of damaged cells with increasing doses of ATO (Fig. 3) .
Comet assay using SYBR green stain
Representative comet assay images of control and ATO-treated HL-60 cells using SYBR green stain are presented in (Fig. 4) . As in the case with silver staining, these results showed a significant (P < 0.05) increase of DNA damage in ATO-treated HL-60 cells compared to the control cells. Data generated from this experiment indicated a gradual increase in the comet tail length, tail moment, tail arm, and percentage of DNA cleavage of HL-60 cells, with increasing doses of ATO (Fig. 4) . After 24 h of exposure, the mean percentages of DNA cleavage of exposure were 1.72 ± 1.9%, 3.25 ± 2.3%, 12.02 ± 8.3%, and 18.87 ± 6.8% in 0, 2.5, 5, and 10 lg/mL of ATO, respectively. Similarly, the mean values tail length were computed to be 1 ± 2, 3 ± 2, 17 ± 12, and 24 ± 14 lM in 0, 2.5, 5, and 10 lg/ mL, respectively; showing a clear evidence that ATO causes DNA damage in a dose-dependent manner (Fig. 5) .
Discussion
Cytotoxicity/MTT assay Cytotoxicity can be defined as the cell killing property of a chemical compound independent from the mechanism of death. In this research, we examined the cytotoxic effect of ATO on the HL-60 cells. Findings from our study clearly demonstrated that ATO is highly cytotoxic to human leukemia (HL-60) cells, showing a 24 h-LD 50 of 6.4 ± 0.6 lg/mL. Recently, we also reported that ATO is cytotoxic to human liver carcinoma (HepG 2 ) cells, showing a 48 h-LD 50 of 8.55 ± 0.58 lg/ml [20] . These results indicate that HL-60 cells are more sensitive to ATO toxicity than HepG 2 cells. Several studies have addressed the cytotoxicity of arsenic to various cells. One of such studies has shown that exposure to ATO within the dose range of , and 10 lg/mL). Each point represents a mean ± SD of three experiments. Comets were randomly selected from three replicated slides and grouped into five classes based on the degree of DNA damage and the comet tail length, as described in the Materials and methods 0.5-1 lM/L induces apoptosis in monocytic (NB 4 ) cells [29] . Cytotoxicity studies with two multiple myeloma (MM)-derived cell lines, RPMI 8226 and U266, have reported that exposure to 1.0 lM/L ATO inhibits cell proliferation resulting in a weak degree of apoptosis induction, while an exposure of 2.0 lM/L strongly induces cell apoptosis. These investigations pointed out that ATO exerts apoptosis-inducing and growthinhibiting effects on MM-derived cells [30] . Findings from other studies suggest that low doses of arsenic are dramatically effective in acute promyelocytic leukemia and show considerable promise in preclinical models of other tumor types [31] .
Comet/genotoxicity assay Comet assay, also known as single cell gel electrophoresis (SCGE), is a microgel electrophoresis technique, which detects DNA damage and repair in individual cells [32] . In the comet assay, a damaged cell takes on the appearance of a comet, with head and tail regions. The head corresponds to the amount of DNA that still remains in the region of the nuclear matrix, whereas the tail visualizes the fragments of DNA migrating from the nucleus [33] . By means of the comet assay, the present study has elucidated some of the molecular changes in HL-60 cells exposed to ATO. Similar to those reported in previous literature, our results demonstrate that ATO induces DNA damage in a dose-dependent manner.
In the SYBR green-staining protocol, a variety of geometric and densitometric parameters are provided by the image analysis software, which allows an estimation of the amount of DNA in the head and tail regions and the extent of migration into the tail region. Our data show individually isolated nuclei in cells comprising heads and tails, forming comet images (Figs. 2, 4) . Also, these data indicate that the amount of DNA liberated from the nuclei of HL-60 cells is highly dependent on the ATO dose. The mean values of tail length were computed to be 1 ± 2, 3 ± 2, 17 ± 12, and 24 ± 14 lM in 0, 2.5, 5, and 10 lg/mL, respectively; indicating that ATO is a potent inducer of DNA damage. Other toxic end points including tail moment, tail area, and percentage of DNA damage also follow the same pattern. Our findings are consistent with those of previous literature reporting an elevated level of DNA damage in cervical epithelial cells, and peripheral blood leucocytes of cervix cancer patients and patients with pre-cancerous lesions categorized into mild and severe dysplasia [34] .
In this research, we estimated DNA damage in HL-60 cells using both silver, and SYBR green staining protocols. We did not find any significant differences in comet images using the two staining techniques. However, the silver-staining protocol only provided a qualitative analysis whereas SYBR greenstaining provided both qualitative and quantitative assessments. Both protocols confirm that the comet assay is a sensitive and effective method for detecting DNA damage caused by heavy metals such as arsenic. The genotoxic effect by ATO was significantly higher at the 5 and 10 lg/mL dose levels (mean tail lengths of 17 ± 12 and 24 ± 14 lM, respectively) compared to the control (1 ± 2 lM). In general, the extent of DNA damage increased proportionately with increasing doses of ATO. The migration of the DNA from the head region into the tail region reflects the number of single-strand breaks in the DNA. No data was found in the literature regarding the genotoxicity of ATO to human leukemia (HL-60) cells. Here, we report for the first time the genotoxic effect of ATO to these cells using the alkaline single cell gel electophoresis assay.
Conclusions
Arsenic trioxide (ATO) exposure above 0.08 lg/mL exerts a potent cytotoxic effect on human leukemia (HL-60) cells by inhibiting cell proliferation and inducing cell death. Using the MTT assay, we found a strong dose-response relationship between the degree of cytotoxicity and ATO exposure level; yielding a 24 h-LD 50 of 6.4 ± 0.6 lg/mL. Such cytotoxic effects have been observed in other cell lines and animal models, as well as in clinical studies. Data generated from comet assay indicate that ATO also has a high genotoxic potential. We found that exposure to this compound significantly induces a substantial amount of DNA damage in HL-60 cells. Taken together, our research demonstrates ATO is highly cytotoxic and genotoxic to HL-60 cells. These findings provide new insights in the understanding of the use of ATO as a salvage therapy in the treatment of acute promyelocytic leukemia.
